ConsumerDaily Briefs

Daily Brief Consumer: Tianneng Power International, Fast Retailing, Perfect Medical Health, Alibaba Group, China Education Group, Tesla Motors, National Vision Holdings and more

In today’s briefing:

  • Tianneng (819 HK): EV Battery Play Seeks Swiss Listing
  • Fast Retailing (9983) | Q1 Miss
  • Perfect Medical: Reopening in China to Provide a Boost, Rally to Sustain
  • Alibaba Signs Cooperation Agreement With Hangzhou Government
  • China Education Group (839 HK): Solidifying Investment Thesis After Placement
  • What Is Tesla’s Outlook After It Drops Out Of Top 10 Largest U.S. Public Companies?
  • National Vision Holdings, Inc. (EYE) Recommendation: Sell Short

Tianneng (819 HK): EV Battery Play Seeks Swiss Listing

By David Blennerhassett


Fast Retailing (9983) | Q1 Miss

By Mark Chadwick

  • We remain bearish on Fast Retailing given its valuation premium versus global peers
  • Q1 sales were resilient despite global cost of living issues. Profits missed on rising costs and China’s Covid hangover 
  • Cost pressures on the wage bill could be a multi-year issue as Uniqlo seeks to align with global pay standards

Perfect Medical: Reopening in China to Provide a Boost, Rally to Sustain

By Sameer Taneja

  • China ( >20% of revenue ) changing its stance on COVID provides Perfect Medical Health (1830 HK) with an opportunity to crystallize its expansion plans there. 
  • The border reopening between HK/China will provide a boost to its HK operations (>70% of revenue). The second half of H1 2023 results reflect an improving revenue trend for HK.
  • The stock trades at 16x/11x FY23e/24e with ~15% of the market cap in cash and a dividend yield of 6.5%/9.5% FY23e/24e (based on ~100% payout ratio). 

Alibaba Signs Cooperation Agreement With Hangzhou Government

By Caixin Global

  • Chinese e-commerce giant Alibaba Group Holding Ltd. signed a strategic cooperation agreement with the government of Hangzhou, the eastern China city where the company is headquartered
  • Alibaba and its finance affiliate Ant Group Co. Ltd. have been at the center of the Chinese government’s multi-year crackdown on the internet sector since October 2020.
  • In 2021, Alibaba was fined a record 18.2 billion yuan ($2.6 billion) for monopolistic behavior.

China Education Group (839 HK): Solidifying Investment Thesis After Placement

By Osbert Tang, CFA

  • Positive response of China Education Group (839 HK)‘s placement indicated a good return of investor appetite to the sector. Its premium multiples stay well justified even after recent rally. 
  • The HK$1.6bn proceeds will reduce gearing to 29.2% (including contract liabilities) from 41.7% with minimal dilution. Narrowing in valuation gap against asking price of targets means more M&A potential. 
  • More funding for expansion of existing campuses, increase in accommodation and the set up of COVID-19 related curriculum will allow CEG to realise higher revenue per student.

What Is Tesla’s Outlook After It Drops Out Of Top 10 Largest U.S. Public Companies?

By Vladimir Dimitrov, CFA

  • Tesla’s disastrous performance has resulted in the company no longer being among the Top 10 largest U.S. public companies.
  • Market commentators remain laser-focused on business fundamentals, while outside factors are still in the driver’s seat.
  • Back in April of last year (less than a year ago) the optimism on Wall Street was running high.

National Vision Holdings, Inc. (EYE) Recommendation: Sell Short

By Eric Fernandez, CFA

  • Sales have fallen for four quarters. Comp store sales growth fell -8% last quarter due to customer weakness, the declining macro environment and constraints on exam capacity (optometrists).
  • Optometrists are supply constrained, which pressure margins from rising compensation. Investor-owned optometry service providers are at a disadvantage competing with professional practices that don’t share fees with investors.
  • National Vision is neither large and vertically integrated like Essilor Luxottica, nor niche focused like Warby Parker is on ecommerce. Their low-price strategy is easily replicable by competitors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars